• Trials and Research

  Anokion Plans to Launch of Phase 1 Trial of Potential MS Therapy ANK-700

  Posted by ms-news-today-moderator on October 14, 2020 at 10:19 am

  

  The U.S. Food and Drug Administration has accepted an investigational new drug application for ANK-700, a potential treatment for MS developed by Anokion. Read the full story here.

  What do you think of this news?

  ms-news-today-moderator replied 3 years, 6 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply